New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For SNE;CAT;HES;BBY;KERX;FURX;JOSB;ROP;MW;RPRX;BBBY From The Last 14 Days
Check below for free stories on SNE;CAT;HES;BBY;KERX;FURX;JOSB;ROP;MW;RPRX;BBBY the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | all recent news | >>
August 26, 2014
07:10 EDTBBYBest Buy sees Q3, Q4 operating income rate up in line with 1H
Subscribe for More Information
07:04 EDTBBYBest Buy sees ongoing softness in mobile phone category
Subscribe for More Information
07:03 EDTBBYBest Buy CFO sees SSS down in low single digits in Q3, Q4
Subscribe for More Information
07:02 EDTBBYBest Buy: Benefits of Renew Blue cost reduction drove Q2 results
Subscribe for More Information
07:01 EDTBBYBest Buy reports Q2 continuing ops EPS 44c, consensus 31c
Subscribe for More Information
August 25, 2014
15:18 EDTBBYNotable companies reporting before tomorrow's open
Notable companies reporting before tomorrow's market open, with earnings consensus, include Best Buy (BBY), consensus 31c; Golar LNG (GLNG), consensus (7c); DSW (DSW), consensus 32c; Tech Data (TECD), consensus 77c; Sanderson Farms (SAFM), consensus $3.82; Movado (MOV), consensus 54c; Trina Solar (TSL), consensus 14c.
14:14 EDTBBYBest Buy technical comments ahead of results
Subscribe for More Information
10:24 EDTBBYBest Buy weekly volatility increases into Q2 and outlook
Subscribe for More Information
06:44 EDTSNESony's PSN back online following cyber attack
Subscribe for More Information
06:04 EDTSNEAmerican Airlines flight diverted as Sony exec receives threat, Re/code reports
Subscribe for More Information
August 24, 2014
16:34 EDTSNESony says PlayStation impacted by Denial of Service attack
Subscribe for More Information
August 22, 2014
11:59 EDTSNEGameStop surges after Q2 EPS, revenue beat expectations
Subscribe for More Information
11:05 EDTRPRXPiper Jaffray biopharm analyst holds an analyst/industry conference call
Subscribe for More Information
09:01 EDTRPRXRepros Therapeutics has favorable near-term catalysts, says BofA/Merrill
BofA/Merrill lowered Repros Therapeutics' price target to $27 from $32 due to competitive pricing and a contraction in the TRT market but says it expects favorable near-term data from Androxal and AndroGel studies. The firm expects the Sept 17 FDA meeting to access DV risks from exogenous testosterone to be favorable. Shares are Buy rated.
06:37 EDTBBYBest Buy weekly volatility elevated into Q2 and outlook
Subscribe for More Information
August 20, 2014
10:39 EDTCATCaterpillar data may be negative for shares in short-term, says Wells Fargo
Subscribe for More Information
10:35 EDTCATCaterpillar reported world Machines sales down 9%
Subscribe for More Information
<< 1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use